mRNA: Removing Bottlenecks in Process Development & Manufacturing

Time: 9:00 am
day: Day One


  • mRNA manufacturing is not yet a platform approach. Standardized products along the processes are needed
  • mRNA is a relatively large molecule, which leads more challenges for downstream purification
  • mRNA is intrinsically unstable and prone to degradation
  • High raw material cost is limiting mRNA commercialization